Patents by Inventor Elisabeth Scalbert

Elisabeth Scalbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminopyrroline compounds
    Patent number: 6300366
    Abstract: Compound of formula (I): in which: n is 1 or 2, X represents alkylene, alkenylene, alkynylene or optionally substituted arylene or heteroarylene, R10 represents hydrogen or alkyl and R11 and R12 together form a bond, or alternatively R12 represents hydrogen or alkyl and R10 and R11 together form a bond, R2, R3 and R4 each independently of the others represents hydrogen, alkyl, hydroxyalkyl, alkoxy, alkoxycarbonyl, aryl, arylalkyl or aryloxyalkyl, or two of R2, R3 and R4 form a cycloalkyl radical. Medicinal products containing the same are useful in the treatment of cardiovascular diseases.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: October 9, 2001
    Assignee: Adir et Compagnie
    Inventors: Pascal Bousquet, Jean-Daniel Ehrhardt, Véronique Bruban, Josiane Feldman, Stephan Schann, Elisabeth Scalbert, Bruno Pfeiffer, Pierre Renard
  • Heterocyclic compounds
    Patent number: 6057317
    Abstract: Compound of formula (I): ##STR1## wherein: Y, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8 and n are as defined in the description, and medicinal products containing the same which are useful as imidazoline receptor ligands.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: May 2, 2000
    Assignee: Adir et Compagnie
    Inventors: Gerald Guillaumet, Jean-Yves Merour, Frederique Touzeau, Bruno Pfeiffer, Pierre Renard, Elisabeth Scalbert
  • Use of benzopyran derivatives for the treatment of pathologies associated with the NA.sup.+ -independent CI-/HCO.sub.3 -exchanger
    Patent number: 5703118
    Abstract: A method of treating a mammal afflicted with a disorder associated with the Na.sup.+ -independent Cl.sup.- /HCO.sub.3 - exchanger comprising the step of administering a compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9, R.sub.10, R.sub.11 and n are as defined in the description, which is effective for alleviating the said disorder.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: December 30, 1997
    Assignee: Adir et Compagnie
    Inventors: Ludovic Durand, Jean-Paul Babingui, Claudie Moulin, Sylvie Robert-Piessard, Guillaume Le Baut, Elisabeth Scalbert, Daniel-Henri Caignard, Pierre Renard